To observe the effects of GPR43 on the regulation of insulin signalling in podocytes, the expression of GPR43 in the kidneys was assayed in patients with various stages of biopsy-proved DN and in diabetic mice. This evidence concerns the gene FFAR2 and liver dysplastic nodule.